GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthaverse SA (WAR:SVE) » Definitions » Inventories, Finished Goods

Synthaverse (WAR:SVE) Inventories, Finished Goods : zł0.00 Mil (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Synthaverse Inventories, Finished Goods?

Synthaverse's annual finished goods declined from Dec. 2021 (zł3.77 Mil) to Dec. 2022 (zł2.70 Mil) and declined from Dec. 2022 (zł2.70 Mil) to Dec. 2023 (zł2.52 Mil).


Synthaverse Inventories, Finished Goods Historical Data

The historical data trend for Synthaverse's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthaverse Inventories, Finished Goods Chart

Synthaverse Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.58 2.64 3.77 2.70 2.52

Synthaverse Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.52 - - -

Synthaverse Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Synthaverse Business Description

Industry
Traded in Other Exchanges
Address
10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.

Synthaverse Headlines

No Headlines